Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

synerrv sdn bhd - desloratadine -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

synerrv sdn bhd - fexofenadine hydrochloride -

Malaysia - engelsk - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

synerrv sdn bhd - fexofenadine hydrochloride -

USA - engelsk - NLM (National Library of Medicine)

pfizer laboratories div pfizer inc - quinupristin (unii: 23ow28rs7p) (quinupristin - unii:23ow28rs7p), dalfopristin (unii: r9m4fje48e) (dalfopristin - unii:r9m4fje48e) - quinupristin 150 mg in 5 ml - to reduce the development of drug-resistant bacteria and maintain the effectiveness of synercid and other antibacterial drugs, synercid should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. synercid is indicated in adults for the treatment of the following infections when caused by susceptible strains of the designated microorganisms. complicated skin and skin structure infections caused by staphylococcus aureus (methicillin susceptible ) or streptococcus pyogenes . (see clinical studies. ) synercid is contraindicated in patients with known hypersensitivity to synercid , or with prior hypersensitivity to other streptogramins (e.g. , pristinamycin or virginiamycin).

Kenya - engelsk - Pharmacy and Poisons Board

syner-med pharmaceuticals (k) ltd gayatri house, icd road, off mombasa road, p.o - ceftazidime pentahydrate usp - powder for injection - ceftazidime pentahydrate usp eq. to ceftazidime 1… - beta-lactamantibacterials: third-generation

Kenya - engelsk - Pharmacy and Poisons Board

syner-med pharmaceuticals (k) ltd icd road, off mombasa road, nairobi - 52096-00200 - cefuroxime axetil usp - tablet - 250mg - beta-lactamantibacterials: second-generation

Kenya - engelsk - Pharmacy and Poisons Board

syner-med pharmaceuticals (k) ltd icd road, off mombasa road, nairobi - 52096-00200 - cefuroxime axetil usp - tablet - 500mg - beta-lactamantibacterials: second-generation

USA - engelsk - NLM (National Library of Medicine)

synergy pharmaceuticals inc. - plecanatide (unii: 7ik8z952ok) (plecanatide - unii:7ik8z952ok) - plecanatide 3 mg - trulance is indicated in adults for the treatment of: trulance is contraindicated in: risk summary plecanatide and its active metabolite are negligibly absorbed systemically following oral administration [see clinical pharmacology (12.3)] and maternal use is not expected to result in fetal exposure to the drug. the available data on trulance use in pregnant women are not sufficient to inform any drug-associated risks for major birth defects and miscarriage. in animal developmental studies, no effects on embryo-fetal development were observed with oral administration of plecanatide in mice and rabbits during organogenesis at doses much higher than the recommended human dosage. the estimated background risk of major birth defects and miscarriage for the indicated population is unknown. all pregnancies have a background risk of birth defect, loss, or other adverse outcomes. in the united states general population, the estimated background risk of major birth defects and miscarriage in clinically recognized

Singapore - engelsk - HSA (Health Sciences Authority)

synerrv (s) pte. ltd. - solifenacin succinate - tablet, film coated - solifenacin succinate 5.0mg

Irland - engelsk - HPRA (Health Products Regulatory Authority)

chanelle medical unlimited company - meloxicam - tablet - 7.5 milligram(s) - oxicams; meloxicam